N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: A comparison with donepezil and rivastigmine
Authors:
- Maria Grazia GiovanniniMGMaria Grazia Giovannini
- 1 October 2007
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 572 (2-3) , 142-150
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226‐90 in rat brain and plasma by reversed‐phase liquid chromatography coupled to electrospray ionization mass spectrometryBiomedical Chromatography, 2003
- Neurobiology of butyrylcholinesteraseNature Reviews Neuroscience, 2003
- Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 ratsJournal of Neural Transmission, 2002
- Butyrylcholinesterase in the life cycle of amyloid plaquesAnnals of Neurology, 1997
- Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils 1 1Edited by A. R. FershtJournal of Molecular Biology, 1997
- Butyrylcholinesterase‐rich neurons in rat brain demonstrated by a sensitive histochemical methodJournal of Comparative Neurology, 1992
- Pseudocholinesterase staining in the primary visual pathway of the macaque monkeyNature, 1982
- A comparative histochemical mapping of the distribution of butyryl cholinesterase in the brains of four species of mammals, including manCells Tissues Organs, 1967
- Cholinesterase Content of Certain Regions of the Spinal Cord as Judged by Histochemical and Cartesian Diver TechniqueActa Physiologica Scandinavica, 1958
- The histochemical localization of cholinesterases in the central nervous system of the ratJournal of Comparative Neurology, 1954